Japan presents a unique landscape for pharmaceutical companies, both domestic and international. The recent study published […]
The medical device industry demands the highest standards of quality and safety for its poducts. ISO […]
Overview: Introduction Six-month review process priority registration expanded PMDA support innovative drug consultation early application feedback […]
Understanding the MAH Japan System In Japan, the Marketing Authorization Holder (MAH) is central in the […]
The recent regulatory changes in Japan’s pharmaceutical sector present a significant opportunity for non-Japanese companies. By […]
A Thriving Landscape in Japan’s Pharma Sector Pharma Japan and Strategic Opportunities are plentiful in Japan. […]
Japan’s Bioeconomy Strategy 2030 marks a transformative approach to integrating biotechnology into Japan’s economic fabric. It’s […]
Once a flourishing beacon of innovation and global leadership, Japan’s pharmaceutical industry has encountered significant headwinds […]